Pharmafile Logo
Pharmafocus logo
Advanced Search

New products behind Lilly growth

October 19, 2007
Sales and Marketing lilly, zyprexa

Sales rose 19% for Lilly in the third quarter of the year, with depression treatment Cymbalta leading the growth in …

News

Pharma consultants on shortlist to help PCTs improve services

October 19, 2007

Fourteen private companies have been awarded favoured supplier status to assist PCTs in their strategic planning and commissioning of services.The …

News

Pfizer abandons Exubera

October 19, 2007
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …

News

10 steps to choosing a marketing agency

October 18, 2007
Medical Communications marketing, strategy

Feature

Underperforming NHS trusts threatened with takeover

October 18, 2007

Health secretary Alan Johnson has warned the worst performing trusts in the NHS that they could face a takeover from …

News

Latest news from Datamonitor

October 18, 2007
Research and Development

Advaxis cancer vaccine shows encouraging resultsBiotechnology company Advaxis has announced positive results from a Phase I/II first-in-man trial of a …

News

NHS spending growth slows

October 12, 2007

The government will increase its health budget by £20 billion over the next three years, but the current record levels …

News

Pfizer to set up separate biotech arm

October 11, 2007
Research and Development

Pfizer has unveiled its new strategy in research and development, including senior appointments and the setting up of an independent …

News

Efficiency drive has saved NHS millions, say ministers

October 11, 2007

New targets set for PCTs have saved the NHS millions, according to new figures released by the Department of Health.Health …

News

Eucreas a step nearer European approval

October 11, 2007
Sales and Marketing

Novartis' new combination drug, Eucreas, is set for approval following recommendation from Europe's medicines regulator. Eucreas is a single-tablet combination …

News

Wyeth names new chief executive

October 10, 2007
Sales and Marketing Pfizer, Wyeth

Wyeth will begin 2008 with a new leader at the helm. Bernard Poussot will become the company's elected president and …

News

Gates Foundation invests $100m in unorthodox research

October 10, 2007
Research and Development

Scientists with novel ideas for research into some of the world's biggest diseases are to be offered a new source …

News

Latest news from Datamonitor

October 9, 2007
Research and Development

Critical Therapeutics starts Phase I trial of zileutonCritical Therapeutics has initiated a phase I clinical trial to assess the safety …

News

Wyeth buys Scottish biotech firm

October 8, 2007
Research and Development

Wyeth is to acquire Haptogen, a biotech research company based in Aberdeen which has a unique approach to targeting the …

News

GSK appoints Witty to top job

October 8, 2007
Sales and Marketing

GlaxoSmithKline has named JP Garnier's successor when he steps down as chief executive at the end of May next year.Andrew …

News

100m boost for NHS innovation

October 8, 2007

A new body has been set up to promote innovation across the NHS and pharmaceutical products will form a key …

News

Eisai to appeal against Alzheimer’s court ruling

October 3, 2007
Alzheimer's, Eisai, NICE

Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …

News

FDA rejects painkiller Prexige

October 3, 2007
Sales and Marketing reg, safety

Novartis has received a "not approvable" letter from the FDA for its painkiller Prexige because of concerns about potential liver …

News

Roche cuts Tarceva price while NICE deliberate

October 3, 2007

Roche has announced that it is to cut the price of its lung cancer treatment Tarceva for a limited time …

News

Latest news from Datamonitor

October 1, 2007
Research and Development

Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026